Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiviral agents: clinical status report.

R J Whitley, C A Alford

    Hospital Practice (Office Ed.)
    |July 1, 1981
    PubMed
    Summary

    Vidarabine (ara-A) is approved for herpes simplex virus encephalitis. However, its effectiveness in immunocompromised patients and neonates with herpes infections requires further clinical study.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of human coronavirus infections on paediatric patients at a tertiary paediatric hospital: a retrospective study of the prepandemic era.

    The Journal of hospital infection·2023
    Same author

    Foreword.

    Perspectives in medical virology·2020
    Same author

    Immunoglobulin determinations in the diagnosis of fetal infection.

    Pediatric clinics of North America·2015
    Same author

    Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.

    Gene therapy·2014
    Same author

    Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2013
    Same author

    Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.

    Clinical pharmacology and therapeutics·2010

    Area of Science:

    • Antiviral chemotherapy
    • Herpes virus infections

    Background:

    • Vidarabine (ara-A) is a key antiviral agent.
    • Focus on herpes infections including HSV encephalitis, zoster, and neonatal herpes.

    Purpose of the Study:

    • Review clinical studies on ara-A for herpes infections.
    • Clarify the role of ara-A in specific patient groups.

    Main Methods:

    • Review of clinical studies on ara-A.
    • Analysis of data for HSV encephalitis, zoster in immunosuppressed, and neonatal herpes.

    Main Results:

    • Ara-A is licensed for HSV encephalitis.
    • The role of ara-A in immunosuppressed patients and neonates is not yet clearly defined.

    Conclusions:

    • Ara-A is established for HSV encephalitis treatment.
    • Further research is needed to define ara-A's role in immunocompromised and neonatal herpes cases.